Tag: One Health

JPIAMR team submitting the EUP OHAMR proposal.

Proposal for European partnership on OHAMR submitted!

Anna SundinNews and press

Last week, we finally submitted the proposal for the Horizon Europe partnership on One Health AntiMicrobial Resistance (EUP OHAMR) to the European Commission (EC).

The EUP OHAMR will consist of 51 organisations from 28 countries that together with the EC will commit over 340 MEUR over 10 years to boost One Health AMR R&I in all its dimensions: coordinating joint transnational calls, actions to strengthen the capacity of the AMR research community, provide frameworks for alignment of policy and stakeholder engagement, and tools to valorise the new knowledge for the benefit of citizens and society as a whole.

Thank you to all partners for your cooporation and support to develop the proposal!

Livestok, petri dish with bacteria, people in city street.

Job vacancies, European partnership on One Health AMR

Anna SundinNews and press

The European partnership on One Health AMR (OHAMR) is one of the key partnerships that has been identified by the European Commission within the framework of the Horizon Europe programme to support Resarch & Innovation to respond to the challenges of antimicrobial resistance (AMR). The first call and launch of other activities of this joint research programme between the European Commission and Member States are planned to take place in 2025.

The new partnership builds on the work of the Joint Programming Initiative on AMR (JPIAMR), but has a bigger ambition, as well as a stronger integration of social sciences and humanities, support of innovation, and international engagement to address the challenges of AMR.

The OHAMR partnership will be coordinated by the Swedish Research Council (SRC), who is currently hosting the JPIAMR secretariat. The SRC is now recruiting a Head of secretariat and a Scientific adviser to join the JPIAMR/OHAMR team in Stockholm, Sweden.

The application deadline for both positions is 20 August 2024.

Head of secretariat, European partnership on One Health AMR for the Swedish Research Council

Ref no: 2.2.1-2024-06278

As Head of the secretariat, you will coordinate and manage the European partnership OHAMR, with support from the secretariat. You will also lead and allocate other tasks within the secretariat, linked to the JPIAMR and other EU projects already in progress in the AMR area. The role requires some travel, primarily within the EU.

The tasks include:

  • Acting as project leader for the Swedish Research Council’s coordination of the European partnership OHAMR. This includes leading the coordination of the international collaboration according to the agreed governance structure of the partnership, and to ensure correct budget follow-up and reporting on the project to the EU.
  • Leading and delegating the work within the OHAMR secretariat, and coordinating the work within OHAMR as well as for the JPIAMR and EU projects within AMR that are already in progress.
  • participating in the Swedish Research Council’s work on establishing and further developing overarching internal procedures for coordination and participation in partnerships.

Your background

We put great emphasis on your personal qualities. To fit in and be happy in the role, we are looking for a person who is committed, proactive, and has well-developed strategic thinking and collaborative abilities. You have a well-developed ability to plan, organise, and communicate tasks in a structured way, at the same time as being flexible and able to adapt when conditions change. You show good judgement in balancing interests and decision-making. You are communicative and have the ability to establish trusting and good relationships in both external and internal contexts. You are good at picking up nuances and acting in a non-prestigious way.

In addition to these personal qualities, you also need to have:

  • an academic degree in medicine and health or another AMR-relevant subject area
  • documented experience of managing a team in major projects of relevance to the position
  • experience of driving projects forward in a structured way and documenting the work on an ongoing basis
  • knowledge of speaking and writing in Swedish
  • good speaking and writing abilities in English, and good ability in presenting results in a way adapted to the target group

It is an advantage if you have:

  • a doctoral degree in medicine and health, or alternatively corresponding meriting experience of relevance to AMR research
  • worked with AMR-related research strategy and/or policy
  • experience of international research collaboration
  • experience of Swedish public administration
  • experience of EU projects/EU administration
  • good speaking and writing abilities in Swedish

More information

See the full job description and information on how to apply on the Swedish Research Council’s website:

.

Scientific adviser to the Swedish Research Council’s international AMR work

Ref no: 2.2.1-2024-06279

As scientific adviser, you will be part of the OHAMR secretariat at the Swedish Research Council and act as deputy project manager of the upcoming European partnership OHAMR. Through operational work within the OHAMR secretariat, you will get a good overview of all the ongoing activities of the partnership, which forms the basis for driving forward and widening the programme in a strategic way, in consultation with the Head of secretariat. The role will periodically require extensive travel.

The tasks include:

  • through strategic scientific work, helping to develop the OHAMR partnership as a central actor within the global AMR research work
  • monitoring and reporting relevant initiatives within antimicrobial resistance, at national, European, and global level, and contributing to linking OHAMR’s internal and external communication in relevant events
  • acting as deputy project manager for the Swedish Research Council’s coordination of the European partnership OHAMR and working operationally with the secretariat’s various activities within OHAMR and other EU projects within AMR
  • participating in the Swedish Research Council’s other national and international work on AMR.

Your background

We put great emphasis on your personal qualities. To fit in and be happy in the role, you need to have very good collaborative abilities and be able to establish trusting and good relationships in both external and internal contexts. You are good at picking up nuances and acting in a non-prestigious way. You have a well-developed ability to plan, organise, and communicate tasks in a structured way, at the same time as being flexible and able to adapt when conditions change. You are a good communicator and show good judgement in balancing interests and decision-making.

In addition to these personal qualities, you also need to have:

  • a doctoral degree in medicine and health, or alternatively corresponding meriting experience of relevance to AMR research
  • experience of international research collaboration
  • experience of representing an organisation in international collaborations
  • good speaking and writing abilities in English, and good ability in presenting results in a way adapted to the target group
  • knowledge of speaking and writing in Swedish

It is an advantage if you have:

  • worked with AMR-related research matters
  • experience of Swedish public administration
  • experience of EU projects/EU administration
  • good speaking and writing abilities in Swedish

More information

See the full job description and information on how to apply on the Swedish Research Council’s website:

Cover and a couple of pages from the draft OHAMR SRIA.

Online Consultation: The Strategic Research and Innovation Agenda of the European partnership OHAMR

Anna SundinNews and press

The European partnership on One Health AMR (OHAMR) is one of the key European partnerships that has been identified by the European commission within the framework of the Horizon Europe programme to support research and innovation to respond to the challenges of AMR. The OHAMR Strategic Research and Innovation Agenda (SRIA) presents the vision, missions, objectives, scientific focus, and implementation plan of the OHAMR, and serves as the strategic foundation of the partnership to guide its future actions:

The OHAMR SRIA is almost finalised, and we now invite researchers, stakeholders, scientists, policymakers, clinicians, patient groups, AMR-related organisations, and others to provide their final feedback by answering a short survey:

A word template of the survey is also available to facilitate the consultation process. However, only the answers collected through the on-line survey tool will be analysed.

The consultation is open until May 30th, 17h CEST.

For questions regarding the consultation, please contact ohamr@vr.se.

For more information about the OHAMR Partnership, visit www.ohamr.eu.

Reports from DESIGN OH AMR consultations available

Anna SundinNews and pressLeave a Comment on Reports from DESIGN OH AMR consultations available

In 2022, the Coordination and Support Action (CSA) DESIGN OH AMR has organised a series of stakeholder and expert consultations to collect input to the update of the research and innovation objectives within the JPIAMR Strategic Research and Innovation Agenda (SRIA). This serves in preparation for the Horizon Europe candidate One Health AMR Partnership.

The reports from the consultations are now available for download.

Now Open: Call on AMR Diagnostics and Surveillance

Anna SundinNews and press

The Call on Diagnostics and Surveillance 2019 will fund joint transnational research projects addressing the development of diagnostic and surveillance tools, technologies and methods to detect antimicrobial resistance (AMR). Projects should address the diagnosis of AMR infections in clinical and veterinary settings, or the surveillance of AMR in humans, animals and the environment. The call promotes projects with impact in low and middle income countries (LMICs) in Asia and Africa.

AMR has become one of the major global health and development challenges of the 21st century. The threat of AMR is particularly high in resource-limited and high-risk settings. This is linked to issues such as weak human and animal health systems; diverse means of food production, processing and consumption; food safety and food security; water, hygiene and sanitation challenges; and the global movement of people and goods.

In response to these challenges, the JPIAMR is pleased to launch this joint transnational call for proposals for innovative research projects on new or improved diagnostic and surveillance strategies, tools, technologies and methods.  The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant.

The total call budget is approx. 20 million Euro.

For full information about the call and the application process, please visit the call page.

The two-step application process (pre-proposal, full proposal) will have the following targeted timetable:

November 15 2018Preannouncement: Antibiotic Awareness Day 2018
December 5 2018Publication of the JPIAMR ERA-NET 2019 Call
February 18 2019 (11:00 CET)Submission deadline for pre-proposals
Mid April 2019Full proposal invitations sent to project coordinators
June 17th 2019 (11:00 CET)Submission deadline for full proposals
Last week September 2019Final funding decision taken by the CSC
Mid October 2019Final funding decision announced to applicants
End of 2019/Early 2020Start of funding

Fourth JPIAMR Network Call Workshop – report and interviews

Anders BjersNews and press

In March researchers gathered in Frankfurt am Main in a final workshop, Maximising Existing and Future Research Efforts and Resource Alignment to Combat AMR, to share some of their activities and findings from research that was supported by funding within the JPIAMR call for networks. Here we present the full workshop report and filmed interviews with some of the funded networks.

The fourth JPIAMR call for networks closed on June 6, 2016. Participating countries in the network call were JPIAMR members: France, Canada, Belgium Spain, the United Kingdom, Germany, Norway, Sweden, and the Netherlands. The coordinators from the countries participating in the call created networks of researchers from many different countries and fields of research.

Major Conclusions

  • The Network funding mechanism facilitated the formation of successful networks in all strategic JPIAMR areas.
  • JPIAMR Network funding allowed Networks to carry out a broad range of activities with different outcomes, including white papers/position papers, conferences/workshops, systematic reviews, Standard Operating Procedures, online courses, guidance documents and journal articles, amongst others.

JPIAMR has the One Health approach as an integral part of the Strategic Research Agenda. This is one of the key strengths of JPIAMR and it is reflected in the diversity of the network topics.

The full workshop report can be downloaded here.

About the participating networks

The assembled networks had emphasis on needs at a National and International level to address AMR, within these areas:

  • Guidelines on use (Human & Veterinary) – Affordable stewardship
  • Surveillance in primary care
  • New anti-infective/ New adjuvant therapies / Alternative approaches
  • Evaluation of risk for generation of resistance in human setting
  • Rapid diagnostic tests
  • Role of environmental factors
  • Infrastructures/Biobanks available relevant to infection and AMR

The networks spanned all of the JPIAMR pillars and were mostly multidisciplinary (spanning at least two pillars). A range of sizes of the networks were represented at the workshop.

Interviews with coordinators of some funded JPIAMR Networks

Research Network: Flies (Diptera: Muscidae) and the Spread of Antimicrobial Resistant Bacteria

Research Network: INFACT – AMR and Intensive Care Units

Research Network: Rapid Diagnostics

Research Network: AMR Stewardship in Hospitals – What Works?

AMR in focus at G 7 Health Ministers meeting in Milan

Anders BjersNews and press

On November 5 and 6, the G7 Ministerial Meeting on Health took place in Milan, Italy. On the agenda for the second day was antimicrobial resistance (AMR). The discussions focused on crucial topics of global health. The aim of the meeting was among else to coordinate global and concrete actions. In that context, participating Health Ministers expressed that they welcome the establishment of the Global AMR R&D Hub and call to ensure it becomes an effective platform to align and increase global investment in much needed R&D based on WHO recommendations, e.g. the Priority Pathogen List (PPL).  They expressed support for the collaboration of the Global AMR R&D Hub with existing international networks and initiatives like the Interagency Coordination Group on AMR, the Global Antibiotic Research & Development Partnership (GARDP), CARB-X and the Joint Programming Initiative on AMR (JPIAMR). G7 Health Ministers expressed support for the development of evidence-based strategies, tools and interventions to fight AMR, and sustain research related to the Strategic Objectives of the WHO Global Action Plan. As well as to promote R&D for new antimicrobials, alternative therapies, vaccines and rapid-point-of care diagnostics, in particular for WHO-defined priority pathogens and tuberculosis.

JPIAMR welcomes the G7 Health Ministers focus on global coordination, supported R&D areas and the many dimensions of Antibiotic Resistance, the impacts are real now. The actions of JPIAMRs 26 member nations concerted efforts to meet human needs- and scientific results are tangible today. JPIAMR has merged the shared Strategic Research Agenda with a One Health approach. A crucial component and strategy since antimicrobial resistance do not adhere to any boundaries. In 2018 JPIAMR launches it´s 6th call: Innovation against antibiotic resistant bacteria – New targets, compounds and tools. This as a direct response to the WHO Priority Pathogens List (PPL). Coordinating participating nations resources for funding research that targets the 12 groups of bacteria and drug-resistant tuberculosis listed by WHO.

JPIAMR also welcome the initiative of the Global AMR R&D Hub, working side by side to ensure that innovation is in focus and not duplication. Seeing that a diverse range of research and resources can match and harness AMR as the multidimensional global threat it is.

Working together makes the difference we need – to harness AMR in time.